Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B) (C-Term) Peptid
Kurzübersicht für Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B) (C-Term) Peptid (ABIN8108158)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- C-Term
-
Verwendungszweck
- PLA2G4B Peptide - C-terminal region
-
Sequenz
- SFREYSAPGV RRTPEEAAAG EVNLSSSDSP YHYTKVTYSQ EDVDKLLHLT
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti- PLA2G4B Antibody (ARP80684_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- PLA2G4B (Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B))
-
Hintergrund
-
Background Information: This locus represents naturally-occurring readthrough transcription between the neighboring jumonji domain containing 7 (JMJD7) and phospholipase A2, group IVB (cytosolic) (PLA2G4B) genes. Readthrough transcripts encode fusion proteins that share amino acid sequence with each individual gene product, including a partial JmjC domain and downstream C2 and phospholipase A2 domains. Alternatively spliced transcript variants have been observed.
Alternative Symbols: HsT16992, cPLA2-beta
-
Molekulargewicht
- 53 kDa
-
Gen-ID
- 8681
-
NCBI Accession
- NP_001108105
-
UniProt
- P0C869
Target
-
